Y-27632 hydrochloride hydrate
Based on 429 publication(s) in Google Scholar
Y-27632 hydrochloride hydrate is a ROCK inhibitor with Ki values of 220 nM and 300 nM for ROCK1 and ROCK2, respectively. Y-27632 hydrochloride hydrate exerts anti-inflammatory and immunomodulatory effects in systemic lupus erythematosus models by inhibiting the ROCK/NF-κB pathway. Y-27632 hydrochloride hydrate enhances autophagy by inhibiting the AKT/mTOR pathway, thereby inducing apoptosis apoptosis in oral squamous cell carcinoma. Y-27632 hydrochloride hydrate induces the formation of tunneling nanotubes in ARPE-19 cells and significantly enhances mitochondrial transfer through these channels. Y-27632 hydrochloride hydrate promotes neurite outgrowth in PC12 cells by activating the Rac1/NOX1/ROS/AKT/PAK1 signaling cascade.
For research use only. We do not sell to patients.
- Purity: 99.65%
- CAS No.: 331752-47-7
- Formula: C14H25Cl2N3O2
- Molecular Weight:338.27
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Y-27632 hydrochloride hydrate
More- Cancer Cell. 2026 May 21:S1535-6108(26)00220-5.
- Nature. 2025 Dec;648(8092):166-172. [Abstract]
- Nature. 2025 Nov;647(8088):257-267. [Abstract]
- Nature. 2025 Feb;638(8049):225-236. [Abstract]
- Cancer Cell. 2024 Jun 10;42(6):1086-1105.e13. [Abstract]
- Cancer Cell. 2023 Jun 12;41(6):1103-1117.e12. [Abstract]
- Cell. 2024 Jul 25;187(15):3936-3952.e19. [Abstract]
- Mol Cancer. 2025 Oct 2;24(1):238. [Abstract]
- Mol Cancer. 2024 Jun 8;23(1):125. [Abstract]
- Mol Cancer. 2024 Jan 10;23(1):12. [Abstract]
- Nat Photonics. 2025 Jul 10.
- Cell Metab. 2026 May 5;38(5):963-980.e12. [Abstract]
- Cell Res. 2023 Dec;33(12):904-922. [Abstract]
- Immunity. 2025 Mar 21:S1074-7613(25)00093-7. [Abstract]
- Immunity. 2022 Apr 12;55(4):686-700.e7. [Abstract]
- Adv Mater. 2025 Aug;37(32):e2419768. [Abstract]
- Cancer Commun (Lond). 2025 Nov 10. [Abstract]
- Nat Methods. 2025 Mar;22(3):510-519. [Abstract]
- Nat Cancer. 2025 May;6(5):768-785. [Abstract]
- Nat Immunol. 2025 Dec;26(12):2218-2226. [Abstract]
- Nat Immunol. 2025 Oct;26(10):1660-1672. [Abstract]
- Nat Genet. 2025 Feb;57(2):369-378. [Abstract]
- Nat Genet. 2024 Feb;56(2):294-305. [Abstract]
- Bioact Mater. 2026 May 28:64:867-882. [Abstract]
- Bioact Mater. 2025 Nov 25:57:646-659. [Abstract]
- Bioact Mater. 2024 Jun 14:40:244-260. [Abstract]
- Bioact Mater. 2023 Mar 20:26:413-424. [Abstract]
- Bioact Mater. 2022 Aug 14:21:69-85. [Abstract]
- Bioact Mater. 2021 Jun 1:7:364-376. [Abstract]
- Cell Stem Cell. 2026 Apr 2;33(4):676-694.e10. [Abstract]
- Cell Stem Cell. 2022 Sep 1;29(9):1366-1381.e9. [Abstract]
- Cell Stem Cell. 2022 Sep 1;29(9):1346-1365.e10. [Abstract]
- Cell Stem Cell. 2020 Oct 1;27(4):646-662.e7. [Abstract]
- Nat Cell Biol. 2022 Jun;24(6):858-871. [Abstract]
- Cancer Res. 2025 Nov 6. [Abstract]
- Cancer Res. 2025 Oct 9. [Abstract]
- Cancer Res. 2025 Aug 29. [Abstract]
- Cancer Res. 2023 Feb 3;83(3):398-413. [Abstract]
- Drug Resist Updat. 2026 Jul:87:101411. [Abstract]
- J Extracell Vesicles. 2026 Feb;15(2):e70238. [Abstract]
- Clin Mol Hepatol. 2023 Apr;29(2):465-481. [Abstract]
- Bone Res. 2022 Jan 3;10(1):1. [Abstract]
- Autophagy. 2025 Dec;21(12):2709-2729. [Abstract]
- Protein Cell. 2021 Feb;12(2):107-127. [Abstract]
- Nat Commun. 2025 Sep 29;16(1):8541. [Abstract]
- Nat Commun. 2025 Aug 5;16(1):7190. [Abstract]
- Nat Commun. 2025 Jul 1;16(1):6016. [Abstract]
- Nat Commun. 2025 Mar 17;16(1):2635. [Abstract]
- Nat Commun. 2025 Mar 26;16(1):2941. [Abstract]
- Nat Commun. 2025 Feb 26;16(1):1999. [Abstract]
- Nat Commun. 2024 Aug 5;15(1):6626. [Abstract]
- Nat Commun. 2024 May 30;15(1):4590. [Abstract]
- Nat Commun. 2024 Mar 11;15(1):2192. [Abstract]
- Nat Commun. 2024 Feb 19;15(1):1493. [Abstract]
- Nat Commun. 2024 Feb 7;15(1):1150. [Abstract]
- Nat Commun. 2023 Aug 8;14(1):4779. [Abstract]
- Nat Commun. 2023 Apr 6;14(1):1912. [Abstract]
- Nat Commun. 2022 Sep 6;13(1):5237. [Abstract]
- Nat Commun. 2022 Jun 1;13(1):3060. [Abstract]
- Nat Commun. 2022 Apr 19;13(1):2028. [Abstract]
- Circ Res. 2020 Oct 9;127(9):1182-1194. [Abstract]
- Exp Mol Med. 2025 Sep;57(9):1940-1950. [Abstract]
- Exp Mol Med. 2023 Jun;55(6):1258-1271. [Abstract]
- Exp Mol Med. 2021 Sep;53(9):1366-1378. [Abstract]
- ACS Nano. 2026 Mar 10;20(9):7679-7692. [Abstract]
- ACS Nano. 2025 Aug 19;19(32):29073-29086. [Abstract]
- Cell Discov. 2026 Feb 10;12(1):11. [Abstract]
- Cell Discov. 2022 Apr 19;8(1):35. [Abstract]
- Cell Discov. 2021 Apr 19;7(1):25. [Abstract]
- Redox Biol. 2025 Jun:83:103615. [Abstract]
- Mol Cell. 2021 Jul 1;81(13):2736-2751.e8. [Abstract]
- Nat Chem Biol. 2026 Feb 13. [Abstract]
- Nat Chem Biol. 2025 Oct 8. [Abstract]
- Gut Microbes. 2022 Jan-Dec;14(1):2139978. [Abstract]
- J Nanobiotechnology. 2025 Aug 21;23(1):579. [Abstract]
- Theranostics. 2023 May 27;13(10):3290-3309. [Abstract]
- Theranostics. 2022 Oct 17;12(17):7250-7266. [Abstract]
- Theranostics. 2022 Mar 21;12(6):2908-2927. [Abstract]
- Theranostics. 2022 Mar 28;12(7):3131-3149. [Abstract]
- Genes Dis. 2026 Apr 24.
- Acta Pharm Sin B. 2023 Jul;13(7):3027-3042. [Abstract]
- J Exp Clin Cancer Res. 2025 Nov 6;44(1):300. [Abstract]
- J Clin Invest. 2025 Aug 12:e188839. [Abstract]
- J Clin Invest. 2025 Jun 2;135(11):e184158. [Abstract]
- J Clin Invest. 2022 Mar 1;132(5):e154993. [Abstract]
- Adv Sci (Weinh). 2026 Mar;13(16):e13310. [Abstract]
- Adv Sci (Weinh). 2026 Jan 21:e18084. [Abstract]
- Adv Sci (Weinh). 2025 Dec 22:e15246. [Abstract]
- Adv Sci (Weinh). 2025 Nov 3:e09151. [Abstract]
- Adv Sci (Weinh). 2025 May;12(20):e2413376. [Abstract]
- Adv Sci (Weinh). 2024 Jul;11(28):e2307216. [Abstract]
- Adv Sci (Weinh). 2024 Feb;11(5):e2303088. [Abstract]
- Adv Sci (Weinh). 2020 Jun 17;7(15):1903583. [Abstract]
- Cell Rep Med. 2026 Feb 17;7(2):102622. [Abstract]
- Cell Rep Med. 2025 Feb 18;6(2):101966. [Abstract]
- Compos B Eng. 2023 Apr 6, 110711.
- Cell Rep Med. 2023 Feb 21;4(2):100911. [Abstract]
- Sci Adv. 2026 Mar 20;12(12):eadz5906. [Abstract]
- Sci Adv. 2025 Sep 5;11(36):eadz0808. [Abstract]
- Sci Adv. 2023 Dec 22;9(51):eadi5683. [Abstract]
- Sci Adv. 2023 Oct 27;9(43):eadg6686. [Abstract]
- Biomaterials. 2024 Mar:305:122462. [Abstract]
- Biomaterials. 2020 Nov:258:120284. [Abstract]
- Biomaterials. 2020 May:240:119849. [Abstract]
- Mol Biomed. 2026 Jun 12;7(1):88. [Abstract]
- Research (Wash D C). 2023 Nov 15:6:0270. [Abstract]
- Chem Eng J. 2024 Apr 1, 485, 149884.
- Chem Eng J. 1 January 2023, 138737.
- Cell Death Dis. 2026 May 8;17(1):609. [Abstract]
- Cell Death Dis. 2026 Mar 26;17(1):381. [Abstract]
- Pharmacol Res. 2025 Nov:221:107996. [Abstract]
- Engineering. 2025 Aug 27.
- Engineering. 2025 Jul 30.
- Cell Death Dis. 2025 May 14;16(1):380. [Abstract]
- Cell Mol Biol Lett. 2025 Jan 29;30(1):14. [Abstract]
- Cell Death Dis. 2024 Aug 3;15(8):559. [Abstract]
- Cell Death Dis. 2023 Apr 20;14(4):280. [Abstract]
- Pharmacol Res. 2023 Jan:187:106615. [Abstract]
- Cell Death Dis. 2022 Aug 24;13(8):730. [Abstract]
- Small. 2025 Oct 14:e05653. [Abstract]
- Small. 2021 Dec;17(52):e2104773. [Abstract]
- Small. 2021 Jul;17(28):e2100546. [Abstract]
- Cancer Lett. 2019 Apr 28:448:117-127. [Abstract]
- J Immunother Cancer. 2025 Jan 7;13(1):e009356. [Abstract]
- J Immunother Cancer. 2024 Apr 19;12(4):e008628. [Abstract]
- Int J Biol Sci. 2022 Aug 29;18(14):5459-5474. [Abstract]
- J Neuroinflammation. 2024 Apr 10;21(1):88. [Abstract]
- EBioMedicine. 2024 Nov:109:105390. [Abstract]
- Microsyst Nanoeng. 2024 Jul 15:10:97. [Abstract]
- Adv Healthc Mater. 2026 Jul;15(26):e71327. [Abstract]
- Adv Healthc Mater. 2025 Sep 18:e01846. [Abstract]
- Adv Healthc Mater. 2021 May;10(10):e2002103. [Abstract]
- Acta Pharmacol Sin. 2026 Jan 16. [Abstract]
- Cell Death Discov. 2023 Jan 25;9(1):32. [Abstract]
- Environ Int. 2025 Jan:195:109266. [Abstract]
- Biomater Res. 2025 Nov 7:29:0280. [Abstract]
- J Transl Med. 2023 Oct 10;21(1):711. [Abstract]
- Dev Cell. 2026 Jun 10.
- Dev Cell. 2025 Jun 25:S1534-5807(25)00362-4. [Abstract]
- Oncogene. 2026 Jun 19. [Abstract]
- Oncogene. 2023 Oct;42(42):3113-3126. [Abstract]
- Small Methods. 2025 Mar;9(3):e2401144. [Abstract]
- Device. 2024 June 12
- Int J Mol Med. 2024 Nov;54(5):99. [Abstract]
- Cell Genom. 2025 Jul 9;5(7):100881. [Abstract]
- Mol Med. 2023 Oct 20;29(1):139. [Abstract]
- Phytother Res. 2024 Apr;38(4):1863-1881. [Abstract]
- J Anim Sci Biotechnol. 2026 Jun 3;17(1):108. [Abstract]
- EMBO Mol Med. 2023 Jan 11;15(1):e16373. [Abstract]
- Br J Cancer. 2026 Jun;134(12):1744-1753. [Abstract]
- Br J Cancer. 2025 Aug 26. [Abstract]
- Stem Cell Res Ther. 2025 May 13;16(1):239. [Abstract]
- Stem Cell Res Ther. 2025 Apr 12;16(1):173. [Abstract]
- Stem Cell Res Ther. 2024 Dec 3;15(1):463. [Abstract]
- Stem Cell Res Ther. 2024 Oct 8;15(1):350. [Abstract]
- ACS Appl Mater Interfaces. 2022 May 25;14(20):23219-23231. [Abstract]
- Stem Cell Res Ther. 2019 May 31;10(1):155. [Abstract]
- Aging Cell. 2026 Feb;25(2):e70402. [Abstract]
- Aging Cell. 2026 Jan 20;25(2):e70352.
- Cell Rep. 2025 Nov 25;44(11):116505. [Abstract]
- Cell Rep. 2023 Oct 5;42(10):113213. [Abstract]
- Cell Rep. 2023 May 2;42(5):112445. [Abstract]
- Cell Rep. 2019 Jan 8;26(2):407-414.e5. [Abstract]
- Cell Prolif. 2025 Jul 16:e70097. [Abstract]
- Cell Prolif. 2024 Jun;57(6):e13599. [Abstract]
- Cell Prolif. 2023 Jan;56(1):e13320. [Abstract]
- Cell Prolif. 2022 Apr;55(4):e13209. [Abstract]
- Neurotherapeutics. 2021 Apr;18(2):1273-1294. [Abstract]
- J Med Chem. 2019 Jul 11;62(13):6083-6101. [Abstract]
- Anal Chem. 2017 Oct 17;89(20):10841-10849. [Abstract]
- Environ Pollut. 2020 Jun:261:114153. [Abstract]
- Fundam Res. 2025 Sep 24.
- Cancer Cell Int. 2024 Jul 25;24(1):263. [Abstract]
- NPJ Regen Med. 2022 Jun 16;7(1):31. [Abstract]
- PLoS Biol. 2025 Dec 19;23(12):e3003552. [Abstract]
- Cell Rep Phys Sci. 2025 Oct 15;6(10).
- Virulence. 2025 Dec;16(1):2542455. [Abstract]
- Virulence. 2025 Dec;16(1):2466482. [Abstract]
- Antioxid Redox Signal. 2025 Nov;43(13-15):709-726. [Abstract]
- JCI Insight. 2024 Apr 23;9(10):e171916. [Abstract]
- Biomater Adv. 2026 May:182:214679. [Abstract]
- Biomater Adv. 2025 Sep:174:214316. [Abstract]
- Biomater Adv. 2024 Feb:157:213751. [Abstract]
- Acta Neuropathol Commun. 2025 May 27;13(1):118. [Abstract]
- Acta Neuropathol Commun. 2024 Sep 14;12(1):150. [Abstract]
- Cell Biosci. 2024 May 22;14(1):65. [Abstract]
- Int Endod J. 2026 Jun 2. [Abstract]
- Int Endod J. 2025 Apr 1. [Abstract]
- Life Sci. 2020 Apr 1:246:117419. [Abstract]
- Food Funct. 2025 Aug 26;16(17):6786-6799. [Abstract]
- J Biol Eng. 2024 Jan 16;18(1):7. [Abstract]
- Hepatol Commun. 2025 Aug 15;9(9):e0778. [Abstract]
- Cells. 2024 Oct 14;13(20):1697. [Abstract]
- Cells. 2024 Aug 31.
- Cells. 2023 Dec 30;13(1):81. [Abstract]
- ACS Biomater Sci Eng. 2023 Feb 13;9(2):856-868. [Abstract]
- ACS Biomater Sci Eng. 2022 Mar 14;8(3):1301-1311. [Abstract]
- Commun Biol. 2026 Apr 9;9(1):780. [Abstract]
- Commun Biol. 2026 Feb 9;9(1):194. [Abstract]
- Commun Biol. 2026 Jan 15;9(1):266. [Abstract]
- Cell Rep Methods. 2024 Sep 16;4(9):100843. [Abstract]
- Cell Rep Methods. 2024 May 20;4(5):100777. [Abstract]
- Pharmaceuticals (Basel). 2026 Jun 22;19(6):964. [Abstract]
- J Integr Agric. 2026 Jun 8.
- Biomed Signal Process Control. 2026 Feb 26.
- Cell Biol Toxicol. 2025 Aug 20;41(1):126. [Abstract]
- Eur J Pharmacol. 2025 Jun 15:997:177623. [Abstract]
- Respir Res. 2022 Mar 25;23(1):70. [Abstract]
- Stem Cell Reports. 2026 Jul 14;21(7):102968. [Abstract]
- ACS Appl Bio Mater. 2026 Jun 27. [Abstract]
- Int J Mol Sci. 2025 May 31;26(11):5306. [Abstract]
- Int Immunopharmacol. 2025 May 16:155:114657. [Abstract]
- Int Immunopharmacol. 2025 Feb 20:148:114068. [Abstract]
- Int J Mol Sci. 2024 Apr 9;25(8):4138. [Abstract]
- Int J Mol Sci. 2023 Oct 31;24(21):15804. [Abstract]
- Int J Mol Sci. 2022 Nov 24;23(23):14637. [Abstract]
- Cell Regen. 2020 Sep 3;9(1):15. [Abstract]
- Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):61. [Abstract]
- Mol Neurobiol. 2024 Oct;61(10):8402-8413. [Abstract]
- Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):19. [Abstract]
- Front Cell Dev Biol. 2021 Jun 24:9:670825. [Abstract]
- J Drug Deliv Sci Technol.
- ACS Omega. 2025 Apr 22;10(17):17228-17236. [Abstract]
- Toxicology. 2024 Nov 9:509:153994. [Abstract]
- Chem Biol Interact. 2021 Oct 1:348:109625. [Abstract]
- Toxicology. 2020 Oct:443:152573. [Abstract]
- Sci Rep. 2025 Mar 12;15(1):8531. [Abstract]
- Sci Rep. 2021 Dec 7;11(1):23564. [Abstract]
- Sci Rep. 2019 Dec 17;9(1):19301. [Abstract]
- Sci Rep. 2017 Dec 19;7(1):17770. [Abstract]
- Cancers (Basel). 2021 Jun 30;13(13):3282. [Abstract]
- Cell Signal. 2025 Nov:135:111981. [Abstract]
- J Cell Mol Med. 2025 Feb;29(4):e70423. [Abstract]
- Adv Ther. 2024 Jul 18.
- Cell Signal. 2024 Aug:120:111223. [Abstract]
- Adv Ther. 2024 April 30.
- Oncol Rep. 2020 Sep;44(3):1266-1274. [Abstract]
- J Cell Mol Med. 2020 Jul;24(14):8179-8193. [Abstract]
- J Inflamm Res. 2026 Jun 8:19:573499. [Abstract]
- Environ Toxicol Pharmacol. 2023 Nov:104:104301. [Abstract]
- Mol Oncol. 2026 May 21. [Abstract]
- iScience. 2026 Mar 26;29(4):115479. [Abstract]
- iScience. 2026 Jan 27;29(2):114786. [Abstract]
- Biomedicines. 2024 Nov 27;12(12):2708. [Abstract]
- Adv Mater Interfaces. 2024 Sep 03.
- iScience. 2023 Aug 29;26(10):107773. [Abstract]
- Biomedicines. 2022 Apr 18;10(4):928. [Abstract]
- iScience. 2021 Oct 19;24(11):103303. [Abstract]
- Bioengineering (Basel). 2020 Dec 18;7(4):164. [Abstract]
- FASEB J. 2026 Mar 31;40(6):e71632. [Abstract]
- Wound Repair Regen. 2025 May-Jun;33(3):e70032. [Abstract]
- Eur J Cell Biol. 2024 May 28;103(2):151427. [Abstract]
- Biology (Basel). 2023 Jun 20;12(6):888. [Abstract]
- FASEB J. 2022 Nov;36(11):e22580. [Abstract]
- J Neurosci. 2021 Jan 20;41(3):392-407. [Abstract]
- Front Physiol. 2020 Jun 30:11:669. [Abstract]
- FEBS J. 2025 Apr;292(7):1696-1709. [Abstract]
- Mol Hum Reprod. 2025 Apr 3;31(2):gaaf017. [Abstract]
- J Virol. 2025 Apr 15;99(4):e0176124. [Abstract]
- J Biol Chem. 2025 Mar;301(3):108235. [Abstract]
- Int J Chron Obstruct Pulmon Dis. 2024 Jul 8:19:1591-1601. [Abstract]
- J Biol Chem. 2023 Dec;299(12):105361. [Abstract]
- BMC Cancer. 2023 Jun 22;23(1):577. [Abstract]
- J Virol. 2023 May 31;97(5):e0177022. [Abstract]
- Eur J Immunol. 2022 Aug;52(8):1308-1320. [Abstract]
- J Virol. 2021 Feb 24;95(10):e02436-20. [Abstract]
- J Cell Physiol. 2026 May;241(5):e70181. [Abstract]
- J Cell Physiol. 2026 Jan;241(1):e70135. [Abstract]
- Regen Ther. 2025 Oct 13:30:875-883. [Abstract]
- Virol J. 2025 Apr 15;22(1):99. [Abstract]
- Life. 2021 Aug 5;11(8):789. [Abstract]
- Nutr Metab. 2020 Oct 26:17:91. [Abstract]
- Adv Redox Res. 2025 Sep.
- Ann Surg Oncol. 2024 Mar;31(3):1996-2007. [Abstract]
- Epigenetics. 2026 Dec;21(1):2606983. [Abstract]
- Biophys J. 2025 Sep 2;124(17):2840-2853. [Abstract]
- J Diabetes Investig. 2026 Jun;17(6):951-960. [Abstract]
- PLoS Negl Trop Dis. 2025 Nov 13;19(11):e0013725. [Abstract]
- J Biochem Mol Toxicol. 2025 Oct;39(10):e70500. [Abstract]
- Stem Cells Int. 2025 Jul 11:2025:5105796. [Abstract]
- J Bone Oncol. 2021 Sep 20:30:100391. [Abstract]
- Int J Biochem Cell Biol. 2025 Sep:186:106820. [Abstract]
- Exp Cell Res. 2025 Jun 2;450(2):114629. [Abstract]
- Cancer Med. 2024 Nov;13(21):e70397. [Abstract]
- Npj Viruses. 2024 Sep 2;2(1):42. [Abstract]
- Vaccines. 2023 May 17;11(5):993. [Abstract]
- J Cancer. 2025 Jun 9;16(8):2613-2625. [Abstract]
- Transl Lung Cancer Res. 2025 Jun 30;14(6):2159-2179. [Abstract]
- Transl Lung Cancer Res. 2024 Oct 31;13(10):2698-2712. [Abstract]
- Reprod Toxicol. 2024 Jan:123:108522. [Abstract]
- J Cancer Res Clin Oncol. 2024 Sep 19;150(9):424. [Abstract]
- Biochem Biophys Rep. 2022 Jul 2:31:101299. [Abstract]
- J Clin Med. 2019 Oct 21;8(10):1751. [Abstract]
- J Immunol Res. 2026;2026(1):e9082774. [Abstract]
- Biol Reprod. 2025 Oct 14;113(4):870-885. [Abstract]
- Food Chem Toxicol. 2024 Nov:193:115039. [Abstract]
- Brain Res. 2021 Dec 15:1773:147684. [Abstract]
- Toxicol Lett. 2026 Mar 8:111874. [Abstract]
- Life Sci Alliance. 2025 Oct 13;9(1):e202403020. [Abstract]
- Tissue Cell. 2025 Aug 28:98:103111. [Abstract]
- BMC Pulm Med. 2023 Dec 13;23(1):505. [Abstract]
- Hum Mol Genet. 2023 Jan 6;32(2):231-243. [Abstract]
- In Vitro Model. 2025 Mar 5;4(1):31-44. [Abstract]
- Cell Biochem Biophys. 2024 Mar;82(1):127-137. [Abstract]
- Theriogenology. 2025 Oct 1:245:117517. [Abstract]
- Biomed Res Int. 2021 May 14:2021:5565748. [Abstract]
- PLoS One. 2025 May 30;20(5):e0324779. [Abstract]
- Hum Cell. 2024 Nov 4;38(1):13. [Abstract]
- EJNMMI Res. 2024 Sep 27;14(1):86. [Abstract]
- Virology. 2024 Dec:600:110233. [Abstract]
- Virology. 2023 Jun:583:45-51. [Abstract]
- Int J Stem Cells. 2023 May 30;16(2):156-167. [Abstract]
- Biochem Biophys Res Commun. 2023 Aug 6:668:8-18. [Abstract]
- J Biosci Bioeng. 2021 Apr;131(4):434-441. [Abstract]
- Biochem Biophys Res Commun. 2019 Oct 29;519(1):134-140. [Abstract]
- Biochem Biophys Res Commun. 2019 Aug 20;516(2):571-577. [Abstract]
- Med Sci Monit. 2018 May 27:24:3514-3523. [Abstract]
- Arch Oral Biol. 2025 Jan:169:106115. [Abstract]
- BMC Urol. 2021 Jan 6;21(1):5. [Abstract]
- Exp Ther Med. 2021 Apr;21(4):317. [Abstract]
- Can Respir J. 2022 Oct 10:2022:6879539. [Abstract]
- Genes Genomics. 2026 Feb 2. [Abstract]
- Laryngoscope. 2025 Jun 7. [Abstract]
- Tumori. 2024 Oct 27:3008916241291301. [Abstract]
- Curr Med Sci. 2024 Aug;44(4):718-725. [Abstract]
- Connect Tissue Res. 2022 Sep;63(5):475-484. [Abstract]
- Naturwissenschaften. 2025 Jul 23;112(4):53. [Abstract]
- Biosci Biotechnol Biochem. 2021 Sep 22;85(10):2137-2144. [Abstract]
- STAR Protoc. 2026 Feb 23;7(1):104397. [Abstract]
- STAR Protoc. 2026 Feb 19;7(1):104381. [Abstract]
- STAR Protoc. 2023 Feb 3;4(1):102092. [Abstract]
- STAR Protoc. 2021 Nov 5;2(4):100881. [Abstract]
- J Vis Exp. 2026 Apr 3:(230). [Abstract]
- Stem Cell Res. 2026 Mar:91:103910. [Abstract]
- Stem Cell Res. 2025 Dec:89:103866. [Abstract]
- Stem Cell Res. 2025 Sep:87:103752. [Abstract]
- Stem Cell Res. 2025 Jun:85:103693. [Abstract]
- Stem Cell Res. 2024 Apr:76:103327. [Abstract]
- Stem Cell Res. 2024 Jun:77:103399. [Abstract]
- Stem Cell Res. 2022 Sep 15;64:102916. [Abstract]
- Stem Cell Res. 2021 Apr:52:102217. [Abstract]
- Stem Cell Res. 2021 Mar:51:102157. [Abstract]
- BMC Methods. 2026 Jun 11;3(1):27.
- bioRxiv. 2026 Jun 15.
- Autophagy Rep. 2026 Jun 12;5(1):2685472. [Abstract]
- bioRxiv. 2026 Jun 25.
- bioRxiv. 2026 Jun 10.
- bioRxiv. 2026 Apr 13:2026.04.11.717899. [Abstract]
- Res Sq. 2026 Mar 4.
- University of California, Irvine. 2026 Mar 26.
- bioRxiv. 2026 Mar 6.
- bioRxiv. 2026 Mar 16:2026.03.13.711384. [Abstract]
- bioRxiv. 2026 Mar 18.
- bioRxiv. 2026 Feb 13.
- Res Sq. 2026 Feb 2.
- bioRxiv. 2026 Feb 25.
- Res Sq. 2026 Jan 15.
- bioRxiv. 2026 Jan 6.
- bioRxiv. 2026 Jan 17.
- bioRxiv. 2026 Jan 22.
- Res Sq. 2026 Jan 11.
- bioRxiv. 2026 Jan 29:2026.01.28.702105. [Abstract]
- Universite du Quebec. 2025.
- Seoul National University. 2029.
- University of Otago. 2025 Oct 7.
- bioRxiv. 2025 Sep 8:2025.09.05.671511. [Abstract]
- University of California. 2025.
- bioRxiv. 2025 Aug 09.
- SSRN. 2025 Aug 19.
- Res Sq. 2025 Aug 05.
- Res Sq. 2025 Jul 14.
- bioRxiv. 2025 Jun 18.
- Biomed Pharmacother. 2025 May:186:118025. [Abstract]
- Patent. US20250129329A1.
- Res Sq. 2025 May 22.
- bioRxiv. 2025 May 09.
- bioRxiv. 2025 April 30.
- Res Sq. 2025 Apr 24.
- bioRxiv. 2025 April 03.
- Res Sq. 2025 Mar 10.
- bioRxiv. 2025 March 25.
- bioRxiv. 2025 January 15.
- Extracell Vesicle. 2025 Jun.
- bioRxiv. 2025 Feb 22:2025.02.17.638725. [Abstract]
- Patent. US20240319170A1
- Patent. US20240344035A1
- Patent. US20240344020A1
- Methods Mol Biol. 2024:2767:53-62. [Abstract]
- Patent. US20240344020A1.
- bioRxiv. 2024 November 15.
- Research Square Preprint
- Patent. US20240325538A1.
- Patent. US20240344035A1.
- bioRxiv. 2024 November 26.
- Methods Mol Biol. 2024:2767:43-52. [Abstract]
- bioRxiv. 2024 Nov 15:2024.11.13.623500. [Abstract]
- bioRxiv. 2024 September 07.
- bioRxiv. 2024 Aug 12:2024.08.12.607571. [Abstract]
- bioRxiv. 2024 Feb 18.
- Patent. US20240018470A1.
- SSRN. 2024 Jan 22.
- bioRxiv. 2023 Dec 6.
- bioRxiv. 2023 Jun 28.
- bioRxiv. 2023 Jul 1.
- Methods Mol Biol. 2023:2683:53-68. [Abstract]
- bioRxiv. 2023 Jun 22.
- Research Square Preprint. 2023 May 30.
- bioRxiv. 2023 Mar 1.
- bioRxiv. 2023 Feb 24:2023.02.24.529861. [Abstract]
- SSRN. 2023 Feb 6.
- Biomed Pharmacother. 2022 Sep:153:113465. [Abstract]
- Sci Total Environ. 2022 Sep 10;838(Pt 2):155811. [Abstract]
- Patent. US20220267735A1.
- Research (Wash D C). 2022 Aug 3:2022:9832128. [Abstract]
- Research Square Preprint. 2022 Jun.
- Patent. US20220177852A1.
- Bioengineered. 2022 Apr;13(4):8747-8758. [Abstract]
- Research Square Preprint. 2022 Jan.
- bioRxiv. January 16, 2022.
- Research Square Preprint. 2021 Oct.
- Front Med (Lausanne). 2021 Sep 23:8:746298. [Abstract]
- Patent. US20210284970A1.
- Research Square Preprint. 2021 May.
- Mater Sci Eng C Mater Biol Appl. 2021 Mar:122:111939. [Abstract]
- Research Square Preprint. 2021 Jan.
- bioRxiv. 2020 Aug.
- Sci Total Environ. 2020 Jul 10:725:138433. [Abstract]
- bioRxiv. 2020 Mar.
- Oncotarget. 2017 Jul 31;8(47):82506-82530. [Abstract]
-
Histological Imaging/Staining
-
IF
-
WB
-
WB
Biological Activity
Ki: 220/300 nM (ROCK-I/II)[1]
Y-27632 (10 μM; 24-72 h) hydrochloride hydrate significantly reduces the viability of CAL-27, SCC-4 and SCC-9 oral squamous cell carcinoma (OSCC) cells[2].
Y-27632 (10 μM; 24 h) hydrochloride hydrate significantly inhibits the migration of CAL-27, SCC-4 and SCC-9 cells[2].
Y-27632 (10 μM; 6-24 h) hydrochloride hydrate inactivates the AKT/mTOR pathway, reduces the levels of phosphorylated downstream effectors, and increases the levels of apoptosis markers in OSCC cells[2].
Y-27632 (10 μM) hydrochloride hydrate induces autophagy in OSCC cells by inhibiting the mTOR pathway and promoting the conversion of LC3-I to LC3-II[2].
Y-27632 (10-50 μM; 5 min-3 h) hydrochloride hydrate induces dose- and time-dependent neurite outgrowth in PC12 cells via the Rac1/NOX1/ROS/AKT/PAK1 signaling cascade[4].
Y-27632 (10-1000 μM; 24 h) hydrochloride hydrate dose-dependently promotes the formation of F-actin/tubulin-containing Y-NTs (average length 30 µm) in ARPE19 retinal pigment epithelial cells and increases the mitochondrial transfer rate; this effect also exists under photodamage conditions, and mitochondrial transfer depends on direct contact between cells[5].
Y-27632 (40 μM; 24 h) hydrochloride hydrate induces cytoskeleton remodeling and morphological changes (increased cell area, enhanced contour length and pseudopodium formation) in ARPE19 retinal pigment epithelial cells, without altering the protein expression of F-actin or α-tubulin[5].
Y-27632 (40 μM; 24 h) hydrochloride hydrate alters mitochondrial distribution to an infiltrative and axon-like pattern, enhances mitochondrial mobility, upregulates miro1 mRNA expression, and increases the number and length of individual mitochondria in ARPE19 retinal pigment epithelial cells[5].
Y-27632 (10-1000 μM; 24 h) hydrochloride hydrate reduces the viability and promotes the apoptosis of ARPE19 retinal pigment epithelial cells only when the concentration exceeds 40 μM, and exerts no significant effects at concentrations of 10 μM, 20 μM or 40 μM[5].
Y-27632 (40 μM; 24 h) hydrochloride hydrate induces Y-shaped nanotubes (Y-NTs) in ARPE19 retinal pigment epithelial cells, a process that depends primarily on F-actin; in contrast, Y-27632-enhanced mitochondrial transport via Y-NTs relies on both F-actin and microtubules[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:CAL-27, SCC-4, SCC-9 (human oral squamous cell carcinoma, OSCC)
-
Concentration:10 μM
-
Incubation Time:24 h, 48 h, 72 h
-
Result:Significantly reduced cell viability in all three OSCC cell lines at 24, 48, and 72 h, with statistically significant differencesobserved at each time point compared to controls.
-
Cell Line:CAL-27, SCC-4, SCC-9 (human oral squamous cell carcinoma, OSCC)
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Significantly slowed wound healing in all three OSCC cell lines.
-
Cell Line:PC12 cells
-
Concentration:25 μM
-
Incubation Time:5 min, 15 min, 30 min
-
Result:Induced rapid, time-dependent phosphorylation of PAK1, with increasing phosphorylation observed at 5, 15, and 30 min.
Had its PAK1 phosphorylation-inducing effect significantly attenuated by pretreatment with ROS scavengers, NOX inhibitors, AKT inhibitors, Rac1 inhibitors, or NOX1 knockdown.\nInduced rapid, time-dependent phosphorylation of AKT, with significant increases observed at 5, 15, and 30 min.
Had its AKT phosphorylation-inducing effect significantly attenuated by pretreatment with ROS scavengers, NOX inhibitors, Rac1 inhibitors, or NOX1 knockdown.
Y-27632 (10 mg/kg; i.p.; daily; 21 days) suppresses oral squamous cell carcinoma xenograft growth in nude mice, reducing proliferative tumor cells to 51% without inducing significant toxicity[2].
Y-27632 (5 mg/kg; continuous; 5 days post-I/R) attenuates myocardial ischemia-reperfusion injury in male Sprague-Dawley rats, reducing myocardial infarct size to ~20% of whole heart area and suppressing inflammation, apoptosis, and activation of MAPK and NF-κB signaling pathways[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MRL/MpJ-Faslpr/2 J (MRL/lpr) (female, 8 weeks old, 18-22 g, spontaneous lupus-prone model)[1]
-
Dosage:5 mg/kg
-
Administration:i.v.; single dose
-
Result:Decreased serum levels of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6.
Increased serum levels of anti-inflammatory cytokine IL-10.
Increased the percentage of Treg cells in spleen cells from 4.3% to 6.8%.
Restored the expression of Foxp3 (a Treg marker) in spleen tissues.
Downregulated the expression of ROCK1 and ROCK2.
Inhibited the phosphorylation of NF-κBp65 and IkBα.
Reduced nuclear accumulation of NF-κBp65 in spleen T cells.
-
Animal Model:nude mice (8-week-old, female)[2]
-
Dosage:10 mg/kg
-
Administration:i.p.; daily; 21 days
-
Result:Significantly reduced the rate of tumor formation, average tumor volume, and average tumor weight relative to controls.
Reduced the percentage of Ki67-positive proliferative tumor cells to 51%.
Caused no significant change in mouse body weight during treatment.
Induced no obvious pathological damage in major mouse organs.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 331752-47-7
-
Appearance Solid
-
Molecular Weight 338.27
-
Formula C14H25Cl2N3O2
-
Color White to off-white
-
SMILES
O=C([C@H]1CC[C@](CC1)([H])[C@H](N)C)NC2=CC=NC=C2.Cl.O.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (429)
-
Journal Impact Factor
-
Most Recent
-
-
Nature
2025 Dec;648(8092):166-172. PMID: 41125892 -
Nature
2025 Nov;647(8088):257-267. PMID: 40963028 -
Nature
2025 Feb;638(8049):225-236. PMID: 39843734 -
Cancer Cell
Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer. [Abstract]2024 Jun 10;42(6):1086-1105.e13. PMID: 38788720
Y-27632 hydrochloride hydrate purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 Jun 10;42(6):1086-1105.e13. [Abstract]
Y-27632 (GBCs; 10 uM). Representative H&E of primary RPM tumor (top) vs GBC-derived RPM allograft (bottom) 。All scale bars, 50 μm.
-
Cancer Cell
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma. [Abstract]2023 Jun 12;41(6):1103-1117.e12. PMID: 37207655 -
Cell
Amplification editing enables efficient and precise duplication of DNA from short sequence to megabase and chromosomal scale. [Abstract]2024 Jul 25;187(15):3936-3952.e19. PMID: 38936359 -
Mol Cancer
Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization. [Abstract]2025 Oct 2;24(1):238. PMID: 41039575 -
Mol Cancer
Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer. [Abstract]2024 Jun 8;23(1):125. PMID: 38849860 -
Mol Cancer
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma. [Abstract]2024 Jan 10;23(1):12. PMID: 38200517 -
-
Cell Metab
Psoriasis modulates inflammatory bowel disease risk and intestinal epithelium lipid metabolism via IL-1β-producing macrophages. [Abstract]2026 May 5;38(5):963-980.e12. PMID: 41856104 -
Cell Res
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P. [Abstract]2023 Dec;33(12):904-922. PMID: 37460805 -
Immunity
The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2. [Abstract]2025 Mar 21:S1074-7613(25)00093-7. PMID: 40139186 -
Immunity
Intestinal Tuft-2 cells exert antimicrobial immunity via sensing bacterial metabolite N-undecanoylglycine. [Abstract]2022 Apr 12;55(4):686-700.e7. PMID: 35320705 -
Adv Mater
Noninvasive Optogenetics Realized by iPSC-Derived Tentacled Carrier in Alzheimer's Disease Treatment. [Abstract]2025 Aug;37(32):e2419768. PMID: 40434197 -
Cancer Commun (Lond)
Unfolded protein response kinase PERK supports survival and metastasis of circulating tumor cell clusters via SAM synthesis and H3K4me3-dependent PDGFB signaling. [Abstract]2025 Nov 10. PMID: 41212905 -
Nat Methods
Challenging the Astral mass analyzer to quantify up to 5,300 proteins per single cell at unseen accuracy to uncover cellular heterogeneity. [Abstract]2025 Mar;22(3):510-519. PMID: 39820751 -
Nat Cancer
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. [Abstract]2025 May;6(5):768-785. PMID: 40108413 -
Nat Immunol
2025 Dec;26(12):2218-2226. PMID: 41225178 -
Nat Immunol
Delaying pyroptosis with an AI-screened gasdermin D pore blocker mitigates inflammatory response. [Abstract]2025 Oct;26(10):1660-1672. PMID: 40954252 -
Nat Genet
Multi-omic quantitative trait loci link tandem repeat size variation to gene regulation in human brain. [Abstract]2025 Feb;57(2):369-378. PMID: 39809899 -
Nat Genet
Single-nucleus multi-omic profiling of human placental syncytiotrophoblasts identifies cellular trajectories during pregnancy. [Abstract]2024 Feb;56(2):294-305. PMID: 38267607 -
Bioact Mater
Development of a vascularized multi-organoid-on-a-chip to model the heart-islet axis in diabetic cardiomyopathy. [Abstract]2026 May 28:64:867-882. PMID: 42253918 -
Bioact Mater
Food-derived β-lactoglobulin nanofibrils: An efficacy, safe, and scalable solution to overcome oral insulin delivery challenges. [Abstract]2025 Nov 25:57:646-659. PMID: 41377894 -
Bioact Mater
Creating a bionic scaffold via light-curing liquid crystal ink to reveal the role of osteoid-like microenvironment in osteogenesis. [Abstract]2024 Jun 14:40:244-260. PMID: 38973990 -
Bioact Mater
3D printed pore morphology mediates bone marrow stem cell behaviors via RhoA/ROCK2 signaling pathway for accelerating bone regeneration. [Abstract]2023 Mar 20:26:413-424. PMID: 36969106 -
Bioact Mater
An esterase-responsive ibuprofen nano-micelle pre-modified embryo derived nucleus pulposus progenitor cells promote the regeneration of intervertebral disc degeneration. [Abstract]2022 Aug 14:21:69-85. PMID: 36017070 -
Bioact Mater
2021 Jun 1:7:364-376. PMID: 34466738 -
Cell Stem Cell
Pre-adaptation of stem cell-derived islet organoids to hypoxia via zinc transportation inhibition drives angiogenesis. [Abstract]2026 Apr 2;33(4):676-694.e10. PMID: 41932324 -
Cell Stem Cell
Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. [Abstract]2022 Sep 1;29(9):1366-1381.e9. PMID: 36055192 -
Cell Stem Cell
2022 Sep 1;29(9):1346-1365.e10. PMID: 36055191 -
Cell Stem Cell
Mesenchymal Niche-Derived Neuregulin-1 Drives Intestinal Stem Cell Proliferation and Regeneration of Damaged Epithelium. [Abstract]2020 Oct 1;27(4):646-662.e7. PMID: 32693086 -
Nat Cell Biol
Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction. [Abstract]2022 Jun;24(6):858-871. PMID: 35697783 -
Cancer Res
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Co-evolution in Pancreatic Cancer. [Abstract]2025 Nov 6. PMID: 41196022 -
Cancer Res
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer. [Abstract]2025 Oct 9. PMID: 41066596 -
Cancer Res
CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer. [Abstract]2025 Aug 29. PMID: 40882016 -
Cancer Res
PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells. [Abstract]2023 Feb 3;83(3):398-413. PMID: 36480196 -
Drug Resist Updat
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors. [Abstract]2026 Jul:87:101411. PMID: 42128460 -
J Extracell Vesicles
Extracellular Vesicles Coordinate Bacterial Cloaking in Lung Epithelial Cells to Alleviate Acute Inflammatory Injury. [Abstract]2026 Feb;15(2):e70238. PMID: 41656978 -
Clin Mol Hepatol
Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions. [Abstract]2023 Apr;29(2):465-481. PMID: 36800698 -
Bone Res
2022 Jan 3;10(1):1. PMID: 34975148 -
Autophagy
Classical swine fever virus hijacks ESCRT-III and VPS4A to promote phagophore closure for accelerating mitophagy. [Abstract]2025 Dec;21(12):2709-2729. PMID: 40574328 -
Protein Cell
Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance. [Abstract]2021 Feb;12(2):107-127. PMID: 32448967 -
Nat Commun
Biomimetic organo-hydrogels reveal the adipose tissue local mechanical anisotropy regulates ovarian cancer invasion. [Abstract]2025 Sep 29;16(1):8541. PMID: 41022685 -
Nat Commun
Promoting implant osseointegration via the osteoblast-selective β-amino acid polymer strategy. [Abstract]2025 Aug 5;16(1):7190. PMID: 40764473 -
Nat Commun
2025 Jul 1;16(1):6016. PMID: 40593722 -
Nat Commun
Semi-automated IT-scATAC-seq profiles cell-specific chromatin accessibility in differentiation and peripheral blood populations. [Abstract]2025 Mar 17;16(1):2635. PMID: 40097444 -
Nat Commun
Evolutionary divergence in CTCF-mediated chromatin topology drives transcriptional innovation in humans. [Abstract]2025 Mar 26;16(1):2941. PMID: 40140405 -
Nat Commun
2025 Feb 26;16(1):1999. PMID: 40011454 -
Nat Commun
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer. [Abstract]2024 Aug 5;15(1):6626. PMID: 39103353 -
Nat Commun
2024 May 30;15(1):4590. PMID: 38816360 -
Nat Commun
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models. [Abstract]2024 Mar 11;15(1):2192. PMID: 38467634 -
Nat Commun
Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis. [Abstract]2024 Feb 19;15(1):1493. PMID: 38374043 -
Nat Commun
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation. [Abstract]2024 Feb 7;15(1):1150. PMID: 38326335 -
Nat Commun
Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer. [Abstract]2023 Aug 8;14(1):4779. PMID: 37553345 -
Nat Commun
Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. [Abstract]2023 Apr 6;14(1):1912. PMID: 37024479 -
Nat Commun
PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest. [Abstract]2022 Sep 6;13(1):5237. PMID: 36068222 -
Nat Commun
2022 Jun 1;13(1):3060. PMID: 35650274 -
Nat Commun
Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model. [Abstract]2022 Apr 19;13(1):2028. PMID: 35440562 -
Circ Res
2020 Oct 9;127(9):1182-1194. PMID: 32781905 -
Exp Mol Med
Mitochondrial dysfunction by glyoxalase 1 deficiency disrupts definitive endoderm and alveolar development of human pluripotent stem cells. [Abstract]2025 Sep;57(9):1940-1950. PMID: 40887500 -
Exp Mol Med
piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination. [Abstract]2023 Jun;55(6):1258-1271. PMID: 37332045 -
Exp Mol Med
MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β. [Abstract]2021 Sep;53(9):1366-1378. PMID: 34548615 -
ACS Nano
Topology Outweighs Stiffness: Self-Reinforced Cell Mechanotransduction via Multiaxial Curvature Engineering of Ultrasoft Hydrogels. [Abstract]2026 Mar 10;20(9):7679-7692. PMID: 41733433 -
ACS Nano
Quantitative and Reversible Regulation of Yes-Associated Protein Activity by Ultrasmall Nanoparticle-Mediated Magnetothermal Stimulation of F-Actin. [Abstract]2025 Aug 19;19(32):29073-29086. PMID: 40763353 -
Cell Discov
2026 Feb 10;12(1):11. PMID: 41663379 -
Cell Discov
2022 Apr 19;8(1):35. PMID: 35436988 -
Cell Discov
2021 Apr 19;7(1):25. PMID: 33867522 -
Redox Biol
GPX4 deficiency-induced ferroptosis drives endometrial epithelial fibrosis in polycystic ovary syndrome. [Abstract]2025 Jun:83:103615. PMID: 40253746 -
Mol Cell
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability. [Abstract]2021 Jul 1;81(13):2736-2751.e8. PMID: 33932349 -
Nat Chem Biol
2026 Feb 13. PMID: 41688711 -
Nat Chem Biol
2025 Oct 8. PMID: 41062834 -
Gut Microbes
FABP4 in Paneth cells regulates antimicrobial protein expression to reprogram gut microbiota. [Abstract]2022 Jan-Dec;14(1):2139978. PMID: 36519446 -
J Nanobiotechnology
Blood-brain barrier-penetrating Angiopep-2/Sirtuin 1 nanoparticles rescue sevoflurane neurotoxicity through multi-omics identified necroptosis pathways. [Abstract]2025 Aug 21;23(1):579. PMID: 40841659 -
Theranostics
Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling. [Abstract]2023 May 27;13(10):3290-3309. PMID: 37351165 -
Theranostics
Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling. [Abstract]2022 Oct 17;12(17):7250-7266. PMID: 36438502 -
Theranostics
5-Aminolevulinate improves metabolic recovery and cell survival of the liver following cold preservation. [Abstract]2022 Mar 21;12(6):2908-2927. PMID: 35401816 -
Theranostics
Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke. [Abstract]2022 Mar 28;12(7):3131-3149. PMID: 35547747 -
-
Acta Pharm Sin B
A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. [Abstract]2023 Jul;13(7):3027-3042. PMID: 37521858 -
J Exp Clin Cancer Res
Dual CDK and MEK Inhibition potentiates CD8+ T cell-mediated antitumor immunity by inducing pyroptotic cell death in high-mutational head and neck cancer. [Abstract]2025 Nov 6;44(1):300. PMID: 41194215 -
J Clin Invest
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer models. [Abstract]2025 Aug 12:e188839. PMID: 40794455 -
J Clin Invest
2025 Jun 2;135(11):e184158. PMID: 40454481 -
J Clin Invest
Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage. [Abstract]2022 Mar 1;132(5):e154993. PMID: 35077396 -
Adv Sci (Weinh)
2026 Mar;13(16):e13310. PMID: 41589654 -
Adv Sci (Weinh)
Single-Cell Mitochondrial Lineage Tracing Decodes Fate Decision and Spatial Clonal Architecture in Human Hematopoietic Organoids. [Abstract]2026 Jan 21:e18084. PMID: 41560697 -
Adv Sci (Weinh)
Osmotic Tension Asymmetry Drives Electrotactic Migration via PDLIM7-Polarized Microfilament Coordination in Breast Cancer Cells. [Abstract]2025 Dec 22:e15246. PMID: 41431193 -
Adv Sci (Weinh)
Depletion of Sorcs3 Activates Totipotency in Mouse Embryonic Stem Cells by Modulating Key Signaling Pathways. [Abstract]2025 Nov 3:e09151. PMID: 41178446 -
Adv Sci (Weinh)
Massage-Mimicking Nanosheets Mechanically Reorganize Inter-organelle Contacts to Restore Mitochondrial Functions in Parkinson's Disease. [Abstract]2025 May;12(20):e2413376. PMID: 40223359 -
Adv Sci (Weinh)
Histone H3K18 and Ezrin Lactylation Promote Renal Dysfunction in Sepsis-Associated Acute Kidney Injury. [Abstract]2024 Jul;11(28):e2307216. PMID: 38767134 -
Adv Sci (Weinh)
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy. [Abstract]2024 Feb;11(5):e2303088. PMID: 38018486 -
Adv Sci (Weinh)
Heterogeneous Responses to Mechanical Force of Prostate Cancer Cells Inducing Different Metastasis Patterns. [Abstract]2020 Jun 17;7(15):1903583. PMID: 32775149
Y-27632 hydrochloride hydrate purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2020 Jun 17;7(15):1903583. [Abstract]
Fluorescence imaging of LNCaP cells treated with the F-actin inhibitor cytoskeleton B (CB), microtubule inhibitor nocodazole (NO), FAK inhibitor PF573288 (PF), ROCK inhibitor Y-27632 (Y), and myosin II (Myo-II) inhibitor (-)-blebbistatin ((-)Bl). After the cells were cultured on different substrates for 3 days, inhibitors were added and incubated for 24 h. (green, F-actin; scale bar, 25 µm).
Y-27632 hydrochloride hydrate purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2020 Jun 17;7(15):1903583. [Abstract]
Expression of CTC cluster-related (plakoglobin and CD44) and EMT-related (vimentin and E-cadherin, 4 days) proteins in LNCaP cells grown on different substrates after treatment with different inhibitors (Cytoskeleton B (CB), Nocodazole (NO), PF-573288 (PF), Y-27632 (Y), and (-)-Blebbistatin ((-) Bl)).
-
Cell Rep Med
A human patient-derived organoid biobank to model tumor heterogeneity and therapeutic vulnerability for oral squamous cell carcinoma. [Abstract]2026 Feb 17;7(2):102622. PMID: 41707653 -
Cell Rep Med
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC. [Abstract]2025 Feb 18;6(2):101966. PMID: 39970873 -
-
Cell Rep Med
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study. [Abstract]2023 Feb 21;4(2):100911. PMID: 36657446 -
Sci Adv
Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis. [Abstract]2026 Mar 20;12(12):eadz5906. PMID: 41861024 -
Sci Adv
2025 Sep 5;11(36):eadz0808. PMID: 40911681 -
Sci Adv
Haploid-genetic screening of trophectoderm specification identifies Dyrk1a as a repressor of totipotent-like status. [Abstract]2023 Dec 22;9(51):eadi5683. PMID: 38117886 -
Sci Adv
A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. [Abstract]2023 Oct 27;9(43):eadg6686. PMID: 37889972 -
Biomaterials
FAK-p38 signaling serves as a potential target for reverting matrix stiffness-modulated liver sinusoidal endothelial cell defenestration. [Abstract]2024 Mar:305:122462. PMID: 38171118 -
Biomaterials
2020 Nov:258:120284. PMID: 32798743 -
Biomaterials
2020 May:240:119849. PMID: 32087458 -
Mol Biomed
TELO2-interacting protein 1 (TTI1), a novel Wnt/β-catenin target gene, decreases chemo-sensitivity in colorectal cancer by modulating DNA damage responses. [Abstract]2026 Jun 12;7(1):88. PMID: 42283915 -
Research (Wash D C)
Cell Mechanics Regulates the Dynamic Anisotropic Remodeling of Fibril Matrix at Large Scale. [Abstract]2023 Nov 15:6:0270. PMID: 39882542 -
-
-
Cell Death Dis
MECP2 mutations disrupt pluripotent stem cell fate through remodeling of the three-dimensional genome. [Abstract]2026 May 8;17(1):609. PMID: 42103737 -
Cell Death Dis
Generation of proliferative hESC-derived grape-clustered hepatocyte organoids with multipolar architecture as regenerative counterpart via synergy of YAP and IGF2 pathways. [Abstract]2026 Mar 26;17(1):381. PMID: 41888105 -
Pharmacol Res
Discovery of KMT5A repressed miR-99b cluster with potential to restore chemotherapy sensitivity in gastric cancer by regulating mitochondrial complex II and affecting OXPHOS. [Abstract]2025 Nov:221:107996. PMID: 41109489 -
-
-
Cell Death Dis
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis. [Abstract]2025 May 14;16(1):380. PMID: 40368918 -
Cell Mol Biol Lett
The histone demethylase KDM5C enhances the sensitivity of acute myeloid leukemia cells to lenalidomide by stabilizing cereblon. [Abstract]2025 Jan 29;30(1):14. PMID: 39881283 -
Cell Death Dis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators. [Abstract]2024 Aug 3;15(8):559. PMID: 39097593 -
Cell Death Dis
Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to regulate cytoskeleton and cell adhesion. [Abstract]2023 Apr 20;14(4):280. PMID: 37080972 -
Pharmacol Res
Targeting Type I IFN/STAT1 signaling inhibited and reversed corneal squamous metaplasia in Aire-deficient mouse. [Abstract]2023 Jan:187:106615. PMID: 36535573 -
Cell Death Dis
2022 Aug 24;13(8):730. PMID: 36002449 -
Small
2025 Oct 14:e05653. PMID: 41084392 -
Small
Injectable Immunotherapeutic Thermogel for Enhanced Immunotherapy Post Tumor Radiofrequency Ablation. [Abstract]2021 Dec;17(52):e2104773. PMID: 34729889 -
Small
Supramolecular Nanosubstrate-Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion. [Abstract]2021 Jul;17(28):e2100546. PMID: 34105245 -
Cancer Lett
Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma. [Abstract]2019 Apr 28:448:117-127. PMID: 30742939 -
J Immunother Cancer
Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin's lymphoma via CCR7/ARHGAP18/IKBα signaling activation. [Abstract]2025 Jan 7;13(1):e009356. PMID: 39773566 -
J Immunother Cancer
Dysregulation of CD4+ and CD8+ resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis. [Abstract]2024 Apr 19;12(4):e008628. PMID: 38642938 -
Int J Biol Sci
PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. [Abstract]2022 Aug 29;18(14):5459-5474. PMID: 36147463 -
J Neuroinflammation
Fascin-1 limits myosin activity in microglia to control mechanical characterization of the injured spinal cord. [Abstract]2024 Apr 10;21(1):88. PMID: 38600569 -
EBioMedicine
Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD3ζ from human pluripotent stem cells. [Abstract]2024 Nov:109:105390. PMID: 39383607 -
Microsyst Nanoeng
2024 Jul 15:10:97. PMID: 39015940 -
Adv Healthc Mater
Hepatocellular Carcinoma-on-a-Chip Based on Microfluidic Well Array for Personalized Drug Evaluation. [Abstract]2026 Jul;15(26):e71327. PMID: 42237206 -
Adv Healthc Mater
Therapeutic Targeting of the IRF9/RTN4/RHOA/ROCK Pathway via RVG29-Modified PLGA Nanoparticles and rTMS for Neural and Vascular Regeneration Post-Cerebral Infarction. [Abstract]2025 Sep 18:e01846. PMID: 40968528 -
Adv Healthc Mater
2021 May;10(10):e2002103. PMID: 33586366 -
Acta Pharmacol Sin
PLN-L31A/I40A for the treatment of inherited heart disease caused by PLN-R14del mutations. [Abstract]2026 Jan 16. PMID: 41545752 -
Cell Death Discov
Cortical-blood vessel assembloids exhibit Alzheimer's disease phenotypes by activating glia after SARS-CoV-2 infection. [Abstract]2023 Jan 25;9(1):32. PMID: 36697403 -
Environ Int
Dynamic non-coding RNA biomarker reveals lung injury and repair induced by polystyrene nanoplastics. [Abstract]2025 Jan:195:109266. PMID: 39824028 -
Biomater Res
Distinct Roles of Matrigel Enabled the Production of Expandable Hepatoblast and Polarized Hepatocyte Organoids from Human Embryonic Stem Cells under 3-Dimensional Suspension Conditions. [Abstract]2025 Nov 7:29:0280. PMID: 41209312 -
J Transl Med
Matrix stiffness induces Drp1-mediated mitochondrial fission through Piezo1 mechanotransduction in human intervertebral disc degeneration. [Abstract]2023 Oct 10;21(1):711. PMID: 37817199 -
-
Dev Cell
Conserved signals control self-organization and symmetry breaking of murine bilayered epithelia during development and regeneration. [Abstract]2025 Jun 25:S1534-5807(25)00362-4. PMID: 40592344 -
Oncogene
Early induction of the Rho-GEF ECT2 drives MEK/ERK oncogenic signaling in pancreatic ductal adenocarcinoma. [Abstract]2026 Jun 19. PMID: 42321532 -
Oncogene
CUL4B functions as a tumor suppressor in KRAS-driven lung tumors by inhibiting the recruitment of myeloid-derived suppressor cells. [Abstract]2023 Oct;42(42):3113-3126. PMID: 37653114 -
Small Methods
An Integrated Microcurrent Delivery System Facilitates Human Parathyroid Hormone Delivery for Enhancing Osteoanabolic Effect. [Abstract]2025 Mar;9(3):e2401144. PMID: 39420694 -
-
Int J Mol Med
Molecular mechanisms and clinicopathological characteristics of inhibin βA in thyroid cancer metastasis. [Abstract]2024 Nov;54(5):99. PMID: 39301627 -
Cell Genom
2025 Jul 9;5(7):100881. PMID: 40393458 -
Mol Med
Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles. [Abstract]2023 Oct 20;29(1):139. PMID: 37864185 -
Phytother Res
2024 Apr;38(4):1863-1881. PMID: 38358766 -
J Anim Sci Biotechnol
Dynamic cellular heterogeneity revealed through a time-resolved single-cell atlas: assessment of porcine intestinal organoids as an in vitro model for deoxynivalenol and zearalenone. [Abstract]2026 Jun 3;17(1):108. PMID: 42231404 -
EMBO Mol Med
PGF2α facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR+ CXC chemokine expression. [Abstract]2023 Jan 11;15(1):e16373. PMID: 36511116 -
Br J Cancer
Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial. [Abstract]2026 Jun;134(12):1744-1753. PMID: 41946829 -
Br J Cancer
2025 Aug 26. PMID: 40858831 -
Stem Cell Res Ther
Mesenchymal stem cells derived from hPSC via neural crest attenuate chemotherapy-induced premature ovarian insufficiency by ameliorating apoptosis and oxidative stress in granulosa cells. [Abstract]2025 May 13;16(1):239. PMID: 40361250 -
Stem Cell Res Ther
Small molecules direct the generation of ameloblast-like cells from human embryonic stem cells. [Abstract]2025 Apr 12;16(1):173. PMID: 40221796 -
Stem Cell Res Ther
Dynamic three dimensional environment for efficient and large scale generation of smooth muscle cells from hiPSCs. [Abstract]2024 Dec 3;15(1):463. PMID: 39627821 -
Stem Cell Res Ther
SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3β/β-catenin&ERK signaling. [Abstract]2024 Oct 8;15(1):350. PMID: 39380045 -
ACS Appl Mater Interfaces
Engineering a Mechanoactive Fibrous Substrate with Enhanced Efficiency in Regulating Stem Cell Tenodifferentiation. [Abstract]2022 May 25;14(20):23219-23231. PMID: 35544769 -
Stem Cell Res Ther
Feasibility of repairing full-thickness skin defects by iPSC-derived epithelial stem cells seeded on a human acellular amniotic membrane. [Abstract]2019 May 31;10(1):155. PMID: 31151466 -
Aging Cell
p62/SQSTM1 Condensation Modulates Mitochondrial Clustering to Participate in Mitochondrial Quality Control. [Abstract]2026 Feb;25(2):e70402. PMID: 41674118 -
-
Cell Rep
Tunneling nanotube-mediated stem cell immunomodulation dysfunction promotes adipose inflammation and insulin resistance in GDM. [Abstract]2025 Nov 25;44(11):116505. PMID: 41187060 -
Cell Rep
Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells. [Abstract]2023 Oct 5;42(10):113213. PMID: 37804510 -
Cell Rep
DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β. [Abstract]2023 May 2;42(5):112445. PMID: 37141098 -
Cell Rep
2019 Jan 8;26(2):407-414.e5. PMID: 30625323 -
Cell Prolif
2025 Jul 16:e70097. PMID: 40670295 -
Cell Prolif
ISRIB facilitates the co-culture of human trophoblast stem cells and embryonic stem cells. [Abstract]2024 Jun;57(6):e13599. PMID: 38217296 -
Cell Prolif
Novel strategy for primary epithelial cell isolation: Combination of hyaluronidase and collagenase I. [Abstract]2023 Jan;56(1):e13320. PMID: 35920005 -
Cell Prolif
Genome-scale screening in a rat haploid system identifies Thop1 as a modulator of pluripotency exit. [Abstract]2022 Apr;55(4):e13209. PMID: 35274380 -
Neurotherapeutics
Decreased Level of Exosomal miR-5121 Released from Microglia Suppresses Neurite Outgrowth and Synapse Recovery of Neurons Following Traumatic Brain Injury. [Abstract]2021 Apr;18(2):1273-1294. PMID: 33475953 -
J Med Chem
Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)- N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal Tumors. [Abstract]2019 Jul 11;62(13):6083-6101. PMID: 31250638 -
Anal Chem
Multifrequency Optomechanical Stiffness Measurement of Single Adherent Cells on a Solid Substrate with High Throughput. [Abstract]2017 Oct 17;89(20):10841-10849. PMID: 28895727 -
Environ Pollut
F-53B and PFOS treatments skew human embryonic stem cell in vitro cardiac differentiation towards epicardial cells by partly disrupting the WNT signaling pathway. [Abstract]2020 Jun:261:114153. PMID: 32088431 -
-
Cancer Cell Int
2024 Jul 25;24(1):263. PMID: 39054484 -
NPJ Regen Med
Intestinal stem cell aging signature reveals a reprogramming strategy to enhance regenerative potential. [Abstract]2022 Jun 16;7(1):31. PMID: 35710627 -
PLoS Biol
Aging-related peroxisomal dysregulation disrupts intestinal stem cell differentiation through alterations of very long-chain fatty acid oxidation. [Abstract]2025 Dec 19;23(12):e3003552. PMID: 41417787 -
-
Virulence
A human intestinal organoid derived from fetal human colon cells model for studying enteroviral pathogenesis. [Abstract]2025 Dec;16(1):2542455. PMID: 40745909 -
Virulence
The T-type voltage-gated Ca2+ channel CaV3.1 involves in the disruption of respiratory epithelial barrier induced by Pasteurella multocida toxin. [Abstract]2025 Dec;16(1):2466482. PMID: 39950866 -
Antioxid Redox Signal
Remifentanil Mitigates Hepatic Ischemia/Reperfusion-Induced D1-Medium Spiny Neurons Damage via Fibroblast Growth Factor 18 Upregulation. [Abstract]2025 Nov;43(13-15):709-726. PMID: 40810178 -
JCI Insight
Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets. [Abstract]2024 Apr 23;9(10):e171916. PMID: 38652547 -
Biomater Adv
2026 May:182:214679. PMID: 41499859 -
Biomater Adv
Low-density electrospun fibrous network promotes mechanotransduction and matrix remodeling in fibroblasts. [Abstract]2025 Sep:174:214316. PMID: 40245813 -
Biomater Adv
Physiological cyclic stretching potentiates the cell-cell junctions in vascular endothelial layer formed on aligned fiber substrate. [Abstract]2024 Feb:157:213751. PMID: 38219418 -
Acta Neuropathol Commun
Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination. [Abstract]2025 May 27;13(1):118. PMID: 40420167 -
Acta Neuropathol Commun
Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model. [Abstract]2024 Sep 14;12(1):150. PMID: 39300576 -
Cell Biosci
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT). [Abstract]2024 May 22;14(1):65. PMID: 38778363 -
Int Endod J
2026 Jun 2. PMID: 42227345 -
Int Endod J
Electric field promoted odontogenic differentiation of stem cells from apical papilla by remodelling cytoskeleton. [Abstract]2025 Apr 1. PMID: 40170340 -
Life Sci
Inhibition of RELM-β prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing PLC-mediated KCNK3 decline. [Abstract]2020 Apr 1:246:117419. PMID: 32045592 -
Food Funct
Combination of resveratrol and epirubicin to overcome chemoresistance in lung adenocarcinoma organoids: synergistic effects and translational implications. [Abstract]2025 Aug 26;16(17):6786-6799. PMID: 40755405 -
J Biol Eng
Tissue engineering RPE sheet derived from hiPSC-RPE cell spheroids supplemented with Y-27632 and RepSox. [Abstract]2024 Jan 16;18(1):7. PMID: 38229139 -
Hepatol Commun
Secreted lumican from the tumor microenvironment potentiates HCC stemness and progression. [Abstract]2025 Aug 15;9(9):e0778. PMID: 40824257 -
Cells
Single-Cell Hypertrophy Promotes Contractile Function of Cultured Human Airway Smooth Muscle Cells via Piezo1 and YAP Auto-Regulation. [Abstract]2024 Oct 14;13(20):1697. PMID: 39451215 -
-
Cells
Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma. [Abstract]2023 Dec 30;13(1):81. PMID: 38201285 -
ACS Biomater Sci Eng
Regulation of the Keratocyte Phenotype and Cell Behavior Derived from Human Induced Pluripotent Stem Cells by Substrate Stiffness. [Abstract]2023 Feb 13;9(2):856-868. PMID: 36668685 -
ACS Biomater Sci Eng
Tissue-Engineered Corneal Endothelial Sheets Using Ultrathin Acellular Porcine Corneal Stroma Substrates for Endothelial Keratoplasty. [Abstract]2022 Mar 14;8(3):1301-1311. PMID: 35229601 -
Commun Biol
Enhancing reprogramming towards induced human expanded pluripotency through substitution of SOX2 with engineered SOX17 transcription factors. [Abstract]2026 Apr 9;9(1):780. PMID: 41957290 -
Commun Biol
Wnt11 mediates fibroblast-smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats. [Abstract]2026 Feb 9;9(1):194. PMID: 41663583 -
Commun Biol
Epigenetic and metabolic rewiring in metastatic pheochromocytomas and paragangliomas driven by SDHB mutations. [Abstract]2026 Jan 15;9(1):266. PMID: 41540233 -
Cell Rep Methods
2024 Sep 16;4(9):100843. PMID: 39216483 -
Cell Rep Methods
2024 May 20;4(5):100777. PMID: 38744289 -
Pharmaceuticals (Basel)
Human Hematopoietic Stem Cells Enhance Maturational Differentiation of hiPSC-Derived Cardiomyocytes on Xeno-Free MatriClone-Plastic via EGFR/MAPK/ERK Signaling Pathway. [Abstract]2026 Jun 22;19(6):964. PMID: 42356581 -
-
-
Cell Biol Toxicol
USP18 promotes ferroptosis in lipopolysaccharide-induced human kidney organoids by stabilizing STING1. [Abstract]2025 Aug 20;41(1):126. PMID: 40833519 -
Eur J Pharmacol
Eeyarestatin I (ESI)-induced ERAD inhibition exhibits anti-cancer activity through multiple mechanisms in human colorectal cancer cells. [Abstract]2025 Jun 15:997:177623. PMID: 40222444 -
Respir Res
Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease. [Abstract]2022 Mar 25;23(1):70. PMID: 35337337 -
Stem Cell Reports
Early replication fragile sites are associated with cancer-related CNVs and SNVs in human embryonic stem cells. [Abstract]2026 Jul 14;21(7):102968. PMID: 42314676 -
ACS Appl Bio Mater
Bioinspired Anisotropic Collagen-Based Conductive Hydrogels Promote Neuronal Differentiation via Activation of Mechanoelectrical Signaling. [Abstract]2026 Jun 27. PMID: 42363939 -
Int J Mol Sci
2025 May 31;26(11):5306. PMID: 40508114 -
Int Immunopharmacol
Activating TRPV1 by evodiamine attenuates atherosclerosis by inhibiting endothelial microparticle release. [Abstract]2025 May 16:155:114657. PMID: 40239331 -
Int Immunopharmacol
CD271 regulates osteogenic differentiation of ectomesenchymal stem cells via the RhoA/ROCK signaling pathway. [Abstract]2025 Feb 20:148:114068. PMID: 39826451 -
Int J Mol Sci
Small Molecules Promote the Rapid Generation of Dental Epithelial Cells from Human-Induced Pluripotent Stem Cells. [Abstract]2024 Apr 9;25(8):4138. PMID: 38673725 -
Int J Mol Sci
2023 Oct 31;24(21):15804. PMID: 37958789 -
Int J Mol Sci
Viscoelastic Liquid Matrix with Faster Bulk Relaxation Time Reinforces the Cell Cycle Arrest Induction of the Breast Cancer Cells via Oxidative Stress. [Abstract]2022 Nov 24;23(23):14637. PMID: 36498966 -
Cell Regen
Consistent apparent Young's modulus of human embryonic stem cells and derived cell types stabilized by substrate stiffness regulation promotes lineage specificity maintenance. [Abstract]2020 Sep 3;9(1):15. PMID: 32880028 -
Invest Ophthalmol Vis Sci
Hyperglycemia-Reduced Platelet-Derived Growth Factor-BB Expression Impairs Corneal Wound Healing in Diabetic Mice. [Abstract]2025 Aug 1;66(11):61. PMID: 40856651 -
Mol Neurobiol
LPAR6 Participates in Neuropathic Pain by Mediating Astrocyte Cells via ROCK2/NF-κB Signal Pathway. [Abstract]2024 Oct;61(10):8402-8413. PMID: 38509397 -
Invest Ophthalmol Vis Sci
Retinal Organoid Microenvironment Enhanced Bioactivities of Microglia-Like Cells Derived From HiPSCs. [Abstract]2024 Oct 1;65(12):19. PMID: 39392440 -
Front Cell Dev Biol
Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models. [Abstract]2021 Jun 24:9:670825. PMID: 34249925 -
-
ACS Omega
Royal Jelly Induces Thin Hair Shaft Formation by Suppressing Proliferation of Hair Follicle Stem Cells in Mice. [Abstract]2025 Apr 22;10(17):17228-17236. PMID: 40352556 -
Toxicology
Bisphenol A disrupts the neuronal F-actin cytoskeleton by activating the RhoA/ROCK/LIMK pathway in Neuro-2a cells. [Abstract]2024 Nov 9:509:153994. PMID: 39527977 -
Chem Biol Interact
Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway. [Abstract]2021 Oct 1:348:109625. PMID: 34416245 -
Toxicology
Activation of the RhoA/ROCK pathway contributes to renal fibrosis in offspring rats induced by maternal exposure to di-n-butyl phthalate. [Abstract]2020 Oct:443:152573. PMID: 32860865 -
Sci Rep
Comparative analysis of organoid, air-liquid interface, and direct infection models for studying pathogen-host interactions in endometrial tissue. [Abstract]2025 Mar 12;15(1):8531. PMID: 40075187 -
Sci Rep
Factor quinolinone inhibitors alter cell morphology and motility by destabilizing interphase microtubules. [Abstract]2021 Dec 7;11(1):23564. PMID: 34876605 -
Sci Rep
Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons. [Abstract]2019 Dec 17;9(1):19301. PMID: 31848379 -
Sci Rep
Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL. [Abstract]2017 Dec 19;7(1):17770. PMID: 29259259 -
Cancers (Basel)
Natural Merosesquiterpenes Activate the DNA Damage Response via DNA Strand Break Formation and Trigger Apoptotic Cell Death in p53-Wild-type and Mutant Colorectal Cancer. [Abstract]2021 Jun 30;13(13):3282. PMID: 34209047 -
Cell Signal
2025 Nov:135:111981. PMID: 40639669 -
J Cell Mol Med
Increased Matrix Stiffness Promotes Slow Muscle Fibre Regeneration After Skeletal Muscle Injury. [Abstract]2025 Feb;29(4):e70423. PMID: 39969079 -
-
Cell Signal
Pharmacological control of angiogenesis by regulating phosphorylation of myosin light chain 2. [Abstract]2024 Aug:120:111223. PMID: 38729320 -
-
Oncol Rep
2020 Sep;44(3):1266-1274. PMID: 32582967 -
J Cell Mol Med
Dabigatran ameliorates airway smooth muscle remodeling in asthma by modulating Yes-associated protein. [Abstract]2020 Jul;24(14):8179-8193. PMID: 32542982 -
J Inflamm Res
Unfractionated Heparin Attenuates Histone-Induced Pulmonary Endothelial Glycocalyx Injury: A Preliminary Study on the Roles of the ROCK Pathway and Heparanase‑1. [Abstract]2026 Jun 8:19:573499. PMID: 42292161 -
Environ Toxicol Pharmacol
ZC3H4 Governs Epithelial Cell Migration through ROCK/p-PYK2/p-MLC2 Pathway in Silica-induced Pulmonary Fibrosis. [Abstract]2023 Nov:104:104301. PMID: 37866415 -
Mol Oncol
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer. [Abstract]2026 May 21. PMID: 42169500 -
iScience
Artificial intelligence-driven high-content imaging decodes for NLRP7-mutant recurrent hydatidiform moles. [Abstract]2026 Mar 26;29(4):115479. PMID: 42006372 -
iScience
Biomimetic hydrogel for the construction of patient-derived bladder cancer organoids with aggressive growth. [Abstract]2026 Jan 27;29(2):114786. PMID: 41704753 -
Biomedicines
Precision Treatment of Metachronous Multiple Primary Malignancies Based on Constructing Patient Tumor-Derived Organoids. [Abstract]2024 Nov 27;12(12):2708. PMID: 39767614 -
-
iScience
Mechanosensitive accumulation of non-muscle myosin IIB during mitosis requires its translocation activity. [Abstract]2023 Aug 29;26(10):107773. PMID: 37720093 -
Biomedicines
Generation of a Pure Culture of Neuron-like Cells with a Glutamatergic Phenotype from Mouse Astrocytes. [Abstract]2022 Apr 18;10(4):928. PMID: 35453678 -
iScience
Synthetic liver fibrotic niche extracts achieve in vitro hepatoblasts phenotype enhancement and expansion. [Abstract]2021 Oct 19;24(11):103303. PMID: 34765922 -
Bioengineering (Basel)
Toward Spatial Identities in Human Brain Organoids-on-Chip Induced by Morphogen-Soaked Beads. [Abstract]2020 Dec 18;7(4):164. PMID: 33352983 -
FASEB J
Polyethylene Microplastic Exposure Disrupts Sex and Gut Hormones via Gut Microbial and Metabolic Pathways. [Abstract]2026 Mar 31;40(6):e71632. PMID: 41801048 -
Wound Repair Regen
TWEAK regulates the functions of hair follicle stem cells via the Fn14-Wnt/β-catenin-CXCR4 signalling axis. [Abstract]2025 May-Jun;33(3):e70032. PMID: 40325995 -
Eur J Cell Biol
The mechanical mechanism of angiotensin II induced activation of hepatic stellate cells promoting portal hypertension. [Abstract]2024 May 28;103(2):151427. PMID: 38820882 -
Biology (Basel)
Thermostable Human Basic Fibroblast Growth Factor (TS-bFGF) Engineered with a Disulfide Bond Demonstrates Superior Culture Outcomes in Human Pluripotent Stem Cell. [Abstract]2023 Jun 20;12(6):888. PMID: 37372172 -
FASEB J
Transforming growth factor-β receptor type 2 is required for heparin-binding protein-induced acute lung injury and vascular leakage for transforming growth factor-β/Smad/Rho signaling pathway activation. [Abstract]2022 Nov;36(11):e22580. PMID: 36189652 -
J Neurosci
An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons. [Abstract]2021 Jan 20;41(3):392-407. PMID: 33268543 -
Front Physiol
Notch3 Modulates Cardiac Fibroblast Proliferation, Apoptosis, and Fibroblast to Myofibroblast Transition via Negative Regulation of the RhoA/ROCK/Hif1α Axis. [Abstract]2020 Jun 30:11:669. PMID: 32695015 -
FEBS J
Porphyromonas gingivalis outer membrane vesicles increase vascular permeability by inducing stress fiber formation and degrading vascular endothelial-cadherin in endothelial cells. [Abstract]2025 Apr;292(7):1696-1709. PMID: 39690116 -
Mol Hum Reprod
Mechanical signal-mediated mitochondria-endoplasmic reticulum contacts modulate Leydig cell testosterone biosynthesis during testis development. [Abstract]2025 Apr 3;31(2):gaaf017. PMID: 40419464 -
J Virol
In vivo investigation of PEDV transmission via nasal infection: mechanisms of CD4+ T-cell-mediated intestinal infection. [Abstract]2025 Apr 15;99(4):e0176124. PMID: 40094365 -
J Biol Chem
The Shab family potassium channels are highly enriched at the presynaptic terminals of human neurons. [Abstract]2025 Mar;301(3):108235. PMID: 39880095 -
Int J Chron Obstruct Pulmon Dis
Exercise Attenuate Diaphragm Atrophy in COPD Mice via Inhibiting the RhoA/ROCK Signaling. [Abstract]2024 Jul 8:19:1591-1601. PMID: 39005647 -
J Biol Chem
Multiple N-linked glycosylation sites critically modulate the synaptic abundance of Neuroligin isoforms. [Abstract]2023 Dec;299(12):105361. PMID: 37865312 -
BMC Cancer
Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models. [Abstract]2023 Jun 22;23(1):577. PMID: 37349697 -
J Virol
Intracellular Vimentin Regulates the Formation of Classical Swine Fever Virus Replication Complex through Interaction with NS5A Protein. [Abstract]2023 May 31;97(5):e0177022. PMID: 37129496 -
Eur J Immunol
Differential susceptibility to SARS-CoV-2 in the normal nasal mucosa and in chronic sinusitis. [Abstract]2022 Aug;52(8):1308-1320. PMID: 35524548 -
J Virol
Microfilaments and microtubules alternately coordinate the multi-step endosomal trafficking of Classical Swine Fever Virus. [Abstract]2021 Feb 24;95(10):e02436-20. PMID: 33627389 -
J Cell Physiol
Modeling and Characterization of Intestinal Senescence Using Human Organoids: Insights Into the Epithelial to Mesenchymal Transition. [Abstract]2026 May;241(5):e70181. PMID: 42187232 -
J Cell Physiol
Endoglin Regulates Pluripotency and Differentiation in Human Embryonic Stem Cells Through Wnt and TGF-β Signaling Crosstalk. [Abstract]2026 Jan;241(1):e70135. PMID: 41568654 -
Regen Ther
Primed human pluripotent stem cell-derived blastocyst-like cell aggregates with partial lineage specification. [Abstract]2025 Oct 13:30:875-883. PMID: 41142457 -
Virol J
Long-term culture of chicken tracheal organoids for the purpose of avian influenza virus research. [Abstract]2025 Apr 15;22(1):99. PMID: 40234888 -
Life
2021 Aug 5;11(8):789. PMID: 34440533 -
Nutr Metab
2020 Oct 26:17:91. PMID: 33117428 -
-
Ann Surg Oncol
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers. [Abstract]2024 Mar;31(3):1996-2007. PMID: 38175427 -
Epigenetics
Silencing of optogenetic and chemogenetic transgenes in human iPSCs involves promoter methylation and methylation-independent mechanisms. [Abstract]2026 Dec;21(1):2606983. PMID: 41468306 -
Biophys J
2025 Sep 2;124(17):2840-2853. PMID: 40714842 -
J Diabetes Investig
Effects of imeglimin on experimental diabetic neuropathy in streptozotocin-induced diabetic rats. [Abstract]2026 Jun;17(6):951-960. PMID: 41947182 -
PLoS Negl Trop Dis
Trichinella spiralis serine protease mediates larval invasion of gut epithelium via binding to CK8 and activating RhoA/ROCK1 pathway. [Abstract]2025 Nov 13;19(11):e0013725. PMID: 41231913 -
J Biochem Mol Toxicol
Ketamine Induces Mitochondrial Fission and Dysfunction in Cervical Cancer Cells via RhoA-Dependent DRP-1 Activation. [Abstract]2025 Oct;39(10):e70500. PMID: 40976839 -
Stem Cells Int
2025 Jul 11:2025:5105796. PMID: 40689086 -
J Bone Oncol
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target. [Abstract]2021 Sep 20:30:100391. PMID: 34611509 -
Int J Biochem Cell Biol
Cofilin is a key regulator of oxidative stress-induced intercellular tunneling nanotubes formation. [Abstract]2025 Sep:186:106820. PMID: 40499810 -
Exp Cell Res
Metastatic breast cancer cells adapt to a soft environment with limited involvement of mechanotransduction. [Abstract]2025 Jun 2;450(2):114629. PMID: 40466802 -
Cancer Med
Isobutyric Acid Promotes Immune Evasion in Colorectal Cancer via Increased PD-L1 Expression. [Abstract]2024 Nov;13(21):e70397. PMID: 39503247 -
Npj Viruses
Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression. [Abstract]2024 Sep 2;2(1):42. PMID: 40295820 -
Vaccines
HuNoV Non-Structural Protein P22 Induces Maturation of IL-1β and IL-18 and N-GSDMD-Dependent Pyroptosis through Activating NLRP3 Inflammasome. [Abstract]2023 May 17;11(5):993. PMID: 37243097 -
J Cancer
Resveratrol Induces Oxidative Stress and Downregulates GPX4 and xCT to Activate the Ferroptosis Pathway for Anti-Bladder Cancer Organoids. [Abstract]2025 Jun 9;16(8):2613-2625. PMID: 40535803 -
Transl Lung Cancer Res
Development of a 3D-3 co-culture microbead consisting of cancer-associated fibroblasts and human umbilical vein endothelial cells for the anti-tumor drug assessment of lung cancer. [Abstract]2025 Jun 30;14(6):2159-2179. PMID: 40673102 -
Transl Lung Cancer Res
Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation. [Abstract]2024 Oct 31;13(10):2698-2712. PMID: 39507032 -
Reprod Toxicol
Long-term maintenance of human endometrial epithelial organoids and their stem cell properties. [Abstract]2024 Jan:123:108522. PMID: 38096957 -
J Cancer Res Clin Oncol
MYO3B promotes cancer progression in endometrial cancer by mediating the calcium ion-RhoA/ROCK1 signaling pathway. [Abstract]2024 Sep 19;150(9):424. PMID: 39297944 -
Biochem Biophys Rep
Exosome-mediated transduction of mechanical force regulates prostate cancer migration via microRNA. [Abstract]2022 Jul 2:31:101299. PMID: 35812347 -
J Clin Med
GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease. [Abstract]2019 Oct 21;8(10):1751. PMID: 31640277 -
J Immunol Res
Cold Atmospheric Plasma Enhances Fn14 Signaling in Hair Follicle Stem Cells, Thereby Promoting the Healing of Diabetic Skin Wounds in a Mouse Model. [Abstract]2026;2026(1):e9082774. PMID: 42083508 -
Biol Reprod
Evaluation of optimal trophoblastic models to mimic uterine vessel remodeling in human pregnancy†. [Abstract]2025 Oct 14;113(4):870-885. PMID: 40358012 -
Food Chem Toxicol
Development of a TBXT-EGFP iPS cell model for screening the early developmental toxicity of typical environmental pollutants. [Abstract]2024 Nov:193:115039. PMID: 39389444 -
Brain Res
The ROCK inhibitor Y-27632 ameliorates blood-spinal cord barrier disruption by reducing tight junction protein degradation via the MYPT1-MLC2 pathway after spinal cord injury in rats. [Abstract]2021 Dec 15:1773:147684. PMID: 34634287 -
Toxicol Lett
An in vitro model of bleomycin-induced epithelial injury using stem cell-derived alveolar type 2 epithelial cells. [Abstract]2026 Mar 8:111874. PMID: 41806949 -
Life Sci Alliance
Mitochondrial dysfunction alters early endosome trafficking via microtubule reorganization. [Abstract]2025 Oct 13;9(1):e202403020. PMID: 41083278 -
Tissue Cell
2025 Aug 28:98:103111. PMID: 40902513 -
BMC Pulm Med
Vascular endothelial growth factor induces the migration of human airway smooth muscle cells by activating the RhoA/ROCK pathway. [Abstract]2023 Dec 13;23(1):505. PMID: 38093231 -
Hum Mol Genet
Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber's hereditary optic neuropathy. [Abstract]2023 Jan 6;32(2):231-243. PMID: 35947995 -
In Vitro Model
Colorectal carcinoma organoid and cancer-associated fibroblasts co-culture system for drug evaluation. [Abstract]2025 Mar 5;4(1):31-44. PMID: 40160212 -
Cell Biochem Biophys
LAMB3 Promotes Myofibrogenesis and Cytoskeletal Reorganization in Endometrial Stromal Cells via the RhoA/ROCK1/MYL9 Pathway. [Abstract]2024 Mar;82(1):127-137. PMID: 37801199 -
Theriogenology
2025 Oct 1:245:117517. PMID: 40460471 -
Biomed Res Int
Gentiopicroside Produces Endothelium-Independent Vasodilation by Deactivating the PI3K/Akt/Rho-Kinase Pathway in Isolated Rat Thoracic Aorta. [Abstract]2021 May 14:2021:5565748. PMID: 34095301 -
PLoS One
Construction of a proximity labeling vector to identify protein-protein interactions in human stem cells. [Abstract]2025 May 30;20(5):e0324779. PMID: 40445938 -
Hum Cell
Establishment and drug resistance characterization of paired organoids using human primary colorectal cancer and matched tumor deposit specimens. [Abstract]2024 Nov 4;38(1):13. PMID: 39495391 -
EJNMMI Res
An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study. [Abstract]2024 Sep 27;14(1):86. PMID: 39331331 -
Virology
2024 Dec:600:110233. PMID: 39255726 -
Virology
The ICAM-1 ligand HRV-A89 is internalized independently of clathrin-mediated endocytosis and its capsid reaches late endosomes. [Abstract]2023 Jun:583:45-51. PMID: 37148647 -
Int J Stem Cells
Strategic Application of Epigenetic Regulators for Efficient Neuronal Reprogramming of Human Fibroblasts. [Abstract]2023 May 30;16(2):156-167. PMID: 36823979 -
Biochem Biophys Res Commun
2023 Aug 6:668:8-18. PMID: 37230046 -
J Biosci Bioeng
2021 Apr;131(4):434-441. PMID: 33358352 -
Biochem Biophys Res Commun
Cdc42-mediated supracellular cytoskeleton induced cancer cell migration under low shear stress. [Abstract]2019 Oct 29;519(1):134-140. PMID: 31477271 -
Biochem Biophys Res Commun
Rho-kinase inhibitor attenuates airway mucus hypersecretion and inflammation partly by downregulation of IL-13 and the JNK1/2-AP1 signaling pathway. [Abstract]2019 Aug 20;516(2):571-577. PMID: 31235256 -
Med Sci Monit
Rho Kinase Type 1 (ROCK1) Promotes Lipopolysaccharide-induced Inflammation in Corneal Epithelial Cells by Activating Toll-Like Receptor 4 (TLR4)-Mediated Signaling. [Abstract]2018 May 27:24:3514-3523. PMID: 29804125 -
Arch Oral Biol
The important role of the Wnt/β-catenin signaling pathway in small molecules mediated gingival mesenchymal stem cells transdifferentiate into neuron-like cells. [Abstract]2025 Jan:169:106115. PMID: 39488928 -
BMC Urol
Role of microRNA-381 in bladder cancer growth and metastasis with the involvement of BMI1 and the Rho/ROCK axis. [Abstract]2021 Jan 6;21(1):5. PMID: 33407350 -
Exp Ther Med
The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells. [Abstract]2021 Apr;21(4):317. PMID: 33717260 -
Can Respir J
Effects of Different Intervention Factors on Vascular Endothelial Growth Factor-Induced Human Airway Smooth Muscle Cell Migration. [Abstract]2022 Oct 10:2022:6879539. PMID: 36262381 -
Genes Genomics
Synergistic antitumor activity of CAR-NK cells combined with CAR-macrophages for pancreatic cancer treatment. [Abstract]2026 Feb 2. PMID: 41627624 -
Laryngoscope
2025 Jun 7. PMID: 40481740 -
Tumori
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects. [Abstract]2024 Oct 27:3008916241291301. PMID: 39462833 -
Curr Med Sci
2024 Aug;44(4):718-725. PMID: 38926331 -
Connect Tissue Res
RHOA inhibits chondrogenic differentiation of mesenchymal stem cells in adolescent idiopathic scoliosis. [Abstract]2022 Sep;63(5):475-484. PMID: 35019797 -
Naturwissenschaften
Effects of neural stem cell-derived exosomes on MPTP-induced Parkinson's disease in mice. [Abstract]2025 Jul 23;112(4):53. PMID: 40699331 -
Biosci Biotechnol Biochem
Comparison of gene expression and activation of transcription factors in organoid-derived monolayer intestinal epithelial cells and organoids. [Abstract]2021 Sep 22;85(10):2137-2144. PMID: 34297057 -
STAR Protoc
Protocol for generating an in vitro 3D multicellular culture model of ovarian high-grade serous carcinoma. [Abstract]2026 Feb 23;7(1):104397. PMID: 41734061 -
STAR Protoc
Protocol for generating human tonsil immune organoids with epithelial and germinal center layers using low-Matrigel culture. [Abstract]2026 Feb 19;7(1):104381. PMID: 41722051 -
STAR Protoc
2023 Feb 3;4(1):102092. PMID: 36853659 -
STAR Protoc
2021 Nov 5;2(4):100881. PMID: 34806042 -
J Vis Exp
Generation and Differentiation of Human Olfactory Epithelial Organoids from Adult Stem Cells. [Abstract]2026 Apr 3:(230). PMID: 42008371 -
Stem Cell Res
The establishment of a GPD1L knockout human embryonic stem cell line (WAe009-A-80) using the CRISPR/Cas9 system. [Abstract]2026 Mar:91:103910. PMID: 41539085 -
Stem Cell Res
Generation of integration-free human induced pluripotent stem cell line MUi040-A derived from CD34 + hematopoietic stem cells of a patient with constitutional pericentric inversion of chromosome 9. [Abstract]2025 Dec:89:103866. PMID: 41223746 -
Stem Cell Res
Generation and characterization of human iPSC lines from two patients with therapy-resistant epilepsy carrying nonsense heterozygous variants in the SMC1A gene. [Abstract]2025 Sep:87:103752. PMID: 40541047 -
Stem Cell Res
Generation of human induced pluripotent stem cell line from peripheral blood of patient with lymphedema-distichiasis syndrome. [Abstract]2025 Jun:85:103693. PMID: 40073585 -
Stem Cell Res
Generation of human induced pluripotent stem cell line derived from Becker muscular dystrophy patient with CRISPR/Cas9-mediated correction of DMD gene mutation. [Abstract]2024 Apr:76:103327. PMID: 38324931 -
Stem Cell Res
2024 Jun:77:103399. PMID: 38574666 -
Stem Cell Res
Establishment of two iPSC lines from healthy donor with heterozygous mutation in the SLC26A4 gene. [Abstract]2022 Sep 15;64:102916. PMID: 36126472 -
Stem Cell Res
Establishment of a novel human iPSC line (SDQLCHi032-A) derived from a patient with primary hypertrophic osteoarthropathy caused by HPGD homozygous mutation. [Abstract]2021 Apr:52:102217. PMID: 33550138 -
Stem Cell Res
Establishment of an iPSC line (CSUXHi003-A) from a patient with Waardenburg syndrome type Ⅱ caused by a MITF mutation. [Abstract]2021 Mar:51:102157. PMID: 33454628 -
-
-
Autophagy Rep
Glucose concentration of neuronal media formulations influences PINK1-dependent mitophagy in human iNeurons. [Abstract]2026 Jun 12;5(1):2685472. PMID: 42317396 -
-
-
bioRxiv
ARID1A deficiency unleashes centromeric RNA transcription to drive chromosomal instability and boosts PKMYT1 inhibitor efficacy via RNA sensing. [Abstract]2026 Apr 13:2026.04.11.717899. PMID: 42039593 -
-
-
-
bioRxiv
Spatially Distinct Myosin II Architectures Regulate Protrusion Dynamics and Directional Persistence during Immune Cell Migration. [Abstract]2026 Mar 16:2026.03.13.711384. PMID: 41889862 -
-
-
-
-
-
-
-
-
-
bioRxiv
A HaloTag-4R-Tau Pulse-Chase Sensor Reveals Neddylation Inhibition Promotes Degradation of Tau in iNeurons. [Abstract]2026 Jan 29:2026.01.28.702105. PMID: 41659571 -
-
-
-
bioRxiv
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart. [Abstract]2025 Sep 8:2025.09.05.671511. PMID: 40964318 -
-
-
-
-
-
-
Biomed Pharmacother
Homoharringtonine (omacetaxine mepesuccinate) limits the angiogenic capacity of endothelial cells and reorganises filamentous actin. [Abstract]2025 May:186:118025. PMID: 40184838 -
-
-
-
-
-
-
-
-
-
-
bioRxiv
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancer. [Abstract]2025 Feb 22:2025.02.17.638725. PMID: 40027618 -
-
-
-
Methods Mol Biol
Workflow for Performing Genetic Manipulation in Human Trophoblast Stem Cells Using CRISPR/Cas9 Technology. [Abstract]2024:2767:53-62. PMID: 36515893 -
-
-
Research Square Preprint
-
-
-
-
Methods Mol Biol
2024:2767:43-52. PMID: 36515896 -
bioRxiv
2024 Nov 15:2024.11.13.623500. PMID: 39605338 -
-
bioRxiv
DNA-PKcs Inhibition Improves Sequential Gene Insertion of the Full-Length CFTR cDNA in Airway Stem Cells. [Abstract]2024 Aug 12:2024.08.12.607571. PMID: 39185207 -
-
-
-
-
-
-
Methods Mol Biol
Directed Differentiation of Human iPSCs into Microglia-Like Cells Using Defined Transcription Factors. [Abstract]2023:2683:53-68. PMID: 37300766 -
-
-
-
bioRxiv
2023 Feb 24:2023.02.24.529861. PMID: 36865100 -
-
Biomed Pharmacother
Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma. [Abstract]2022 Sep:153:113465. PMID: 36076577 -
Sci Total Environ
2022 Sep 10;838(Pt 2):155811. PMID: 35597345 -
-
Research (Wash D C)
CNS Organoid Surpasses Cell-Laden Microgel Assembly to Promote Spinal Cord Injury Repair. [Abstract]2022 Aug 3:2022:9832128. PMID: 36061824 -
-
-
Bioengineered
Echinococcus multilocularis drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis. [Abstract]2022 Apr;13(4):8747-8758. PMID: 35324411 -
-
-
-
Front Med (Lausanne)
Amnion-Derived Mesenchymal Stromal/Stem Cell Paracrine Signals Potentiate Human Liver Organoid Differentiation: Translational Implications for Liver Regeneration. [Abstract]2021 Sep 23:8:746298. PMID: 34631757 -
-
-
Mater Sci Eng C Mater Biol Appl
RNA-seq reveals correlations between cytoskeleton-related genes and the osteogenic activity of mesenchymal stem cells on strontium loaded titania nanotube arrays. [Abstract]2021 Mar:122:111939. PMID: 33641927 -
-
-
Sci Total Environ
Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes. [Abstract]2020 Jul 10:725:138433. PMID: 32302844 -
-
Oncotarget
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner. [Abstract]2017 Jul 31;8(47):82506-82530. PMID: 29137281
Y-27632 hydrochloride hydrate purchased from MedChemExpress. Usage Cited in: Oncotarget. 2017 Jul 31;8(47):82506-82530. [Abstract]
SKOV3 mock-transfected control (Ctrl) and shRNA-Hic-5 knockdown (KD) (sh-S1 and sh-S2) cells were either untreated (-) or treated (+) with 10mM Y27632 over a period of 48 hr. SKOV3 mock-transfected control (Ctrl) and shRNA-Hic-5 knockdown (KD) (sh-S1 and sh-S2) clones were either untreated (-) or treated (+) with 10 mM Y27632 followed by stimulation without (-) or with (+) 5 ng/mL of TGFβ1 for 48 hr.
Purity & Documentation
-
Data Sheet (286 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Wang Y, et al. Y-27632, a Rho-associated protein kinase inhibitor, inhibits systemic lupus erythematosus. Biomed Pharmacother. 2017;88:359-366. [Content Brief]
[2]. Wen J, et al. Y-27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors. J Oral Pathol Med. 2025;54(4):207-216. [Content Brief]
[3]. Dong LY, et al. Y-27632, a Rho-kinase inhibitor, attenuates myocardial ischemia-reperfusion injury in rats. Int J Mol Med. 2019;43(4):1911-1919. [Content Brief]
[4]. Park SY, et al. Y-27632 Induces Neurite Outgrowth by Activating the NOX1-Mediated AKT and PAK1 Phosphorylation Cascades in PC12 Cells. Int J Mol Sci. 2020;21(20):7679. Published 2020 Oct 16. [Content Brief]
[5]. Yuan J, et al. ROCK inhibitor enhances mitochondrial transfer via tunneling nanotubes in retinal pigment epithelium. Theranostics. 2024;14(15):5762-5777. Published 2024 Sep 9. [Content Brief]
[6]. Ishizaki T, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol. 2000 May;57(5):976-83. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)